Genedrive collects £0.76m R&D tax credit.


Genedrive said on Friday that it had received a research and development tax credit refund of about £0.76m from HMRC.

  • Genedrive
  • 05 June 2026 12:12:18
Genedrive

Source: Sharecast

The AIM-traded point-of-care pharmacogenetic testing company said the refund related to the financial years ended 30 June 2024 and 30 June 2025.

At 1100 BST, shares in Genedrive were up 4% at 1.3p.

Reporting by Josh White for Sharecast.com.

See latest RNS on Investegate


N/A

ISIN: N/A
Exchange: N/A
Sell:
N/A
Buy:
N/A
Change:
Date:
Prices delayed by at least 15 minutes

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.